SCHEMBL5787463

SCHEMBL5787463

C=CCN(C(=O)OC(C)(C)C)c1cc(OC)c(B(O)O)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
STING1 Q86WV6 1/20 0.32
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PTPN1 P18031 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
GAA P10253 1/20 0.31
MTNR1A P48039 3/20 0.30
MTNR1B P49286 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5788150 0.85 MTNR1A (0.39) TSHRNPSR1ALDH1A1KDM4ETDP1
SCHEMBL30877150 0.77 ALDH1A1 (0.47) TSHRNPSR1ALDH1A1KDM4ETDP1
SCHEMBL4873953 0.77 TSHR (0.44) TSHRNPSR1ALDH1A1KDM4EPTGS1
SCHEMBL5879111 0.77 S1PR1 (0.35) TSHRALDH1A1
SCHEMBL4878325 0.76 TSHR (0.41) TSHRNPSR1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3395276 0.72 TSHR (0.43) TSHRNPSR1KDM4E
SCHEMBL3160825 0.71 TSHR (0.37) TSHRALDH1A1KDM4ESMN1; SMN2KMT2A
SCHEMBL31679552 0.70 HDAC1 (0.37) TSHRNPSR1ALDH1A1KDM4EMEN1
SCHEMBL30877124 0.70 MTNR1A (0.39) TSHRNPSR1PTPN1MTNR1AMTNR1B
SCHEMBL31363146 0.70 KMT2A (0.41) TSHRNPSR1ALDH1A1CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049662-B1 INHIBITORS OF ALPHA4 MEDIATED CELL ADHESION TANABE SEIYAKU CO (JP) 2006-06-21 EP disclosed
US-6855843-B2 Inhibitors of α4 mediated cell adhesion TANABE SEIYAKU CO., LTD. (JP) 2005-02-15 US disclosed
US-20030191118-A1 Inhibitors of alpha4 mediated cell adhesion TANABE SEIYAKU CO., LTD. 2003-10-09 US disclosed
US-6521666-B1 Inhibitors of α4 mediated cell adhesion TANABE SEIYAKU CO., LTD. (JP) 2003-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191118-A1 Inhibitors of alpha4 mediated cell adhesion ITGB4, ITGA4, VCAM1 TSHR 2994/4885NPSR1 1737/4885ALDH1A1 312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.